Survivor Story
When Karen's triple-negative breast cancer returned and spread, she advocated for herself. Today thanks to a clinical trial for immunotherapy, Karen has no evidence of disease.
Read Karen's Story
When Karen's triple-negative breast cancer returned and spread, she advocated for herself. Today thanks to a clinical trial for immunotherapy, Karen has no evidence of disease.
Read Karen's Story
Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.
Learn More
AACR experts forecast advances in cancer research for 2021. Topics include COVID-19, precision medicine, immunotherapy, cancer prevention, early detection, and disparities.
Read the Blog
Prostate cancer is the most common non-skin cancer diagnosed in men. Last year, more than 190,000 men in the United States were diagnosed with this form of cancer, according to federal estimates.
Learn More
Read about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn More
Learn about cancer researchers and physician-scientists like Fellow of the AACR Academy Olufunmilayo (Funmi) Olopade, MD, who are leading advances against cancer.
Learn More
Whether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate Now
The AACR Annual Meeting 2021 will be held over two separate weeks, April 10-15, 2021, and May 17-21, 2021.
Early Registration Deadline: January 15
Achieving the Bold Vision of Health Equity for Racial and Ethnic Minorities and Other Underserved Populations.
Learn MoreThe AACR and our more than 47,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreIncreasing Awareness of Colorectal Cancer Among Hispanics in Puerto Rico. The AACR Cancer Disparities Progress Report 2020
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2019, to July 31, 2020
Learn MoreYour donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Now